Related Experiment Videos
[Bax gene expression in endometrial carcinoma]
1Cancer Institute (Hospital), Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|January 11, 2002
Summary
Bax gene expression is altered in endometrial carcinoma, potentially impacting cell growth and apoptosis. Increased Bax levels correlate with advanced cancer stages, suggesting its role in tumor progression and as a prognostic marker.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Endometrial carcinoma is a common gynecologic malignancy.
- The role of apoptosis-regulating genes, such as BAX, in endometrial cancer development is not fully understood.
Purpose of the Study:
- To investigate the relationship between BAX gene expression and endometrial carcinoma.
- To assess the potential of BAX as a biomarker for tumor progression.
Main Methods:
- Quantitative analysis of BAX mRNA expression using RT-PCR.
- Study cohort included normal proliferative endometrium, simple/complex hyperplasia, atypical hyperplasia, and endometrial carcinoma tissues.
Main Results:
- BAX mRNA expression was observed in all normal proliferative endometrium samples.
- Overexpression of BAX mRNA was detected in atypical hyperplasia and endometrial carcinoma.
- BAX overexpression rates increased with advanced clinical stage, higher histologic grade, deeper myometrial invasion, and lymph node metastasis.
Conclusions:
- BAX gene expression influences the balance between endometrial cell proliferation and apoptosis.
- BAX plays a significant role in endometrial carcinogenesis and tumor progression.
- BAX can serve as a high-risk factor for evaluating the biological behavior of endometrial carcinoma.